发明申请
US20160031859A1 Alkyl [(S)-1-((S)-2--buta-1,3-diynyl)-phenyl]-1H-imidazol-2-yl}-pyrrolidine-1-carbonyl)-2-methyl-propyl]-carbamate naphthalene-1,5-disulfonate, pharmaceutical composition, medicament, method for treatment of viral diseases 审中-公开
- [(S)-1 - ((S)-2-丁-1,3-二炔基) - 苯基] -1H-咪唑-2-基} - 吡咯烷-1-羰基)-2-甲基 - 丙基] - 氨基甲酸萘-1,5-二磺酸盐,药物组合物,药物,治疗病毒性疾病的方法

  • 专利标题: Alkyl [(S)-1-((S)-2--buta-1,3-diynyl)-phenyl]-1H-imidazol-2-yl}-pyrrolidine-1-carbonyl)-2-methyl-propyl]-carbamate naphthalene-1,5-disulfonate, pharmaceutical composition, medicament, method for treatment of viral diseases
  • 专利标题(中): - [(S)-1 - ((S)-2-丁-1,3-二炔基) - 苯基] -1H-咪唑-2-基} - 吡咯烷-1-羰基)-2-甲基 - 丙基] - 氨基甲酸萘-1,5-二磺酸盐,药物组合物,药物,治疗病毒性疾病的方法
  • 申请号: US14798541
    申请日: 2014-02-04
  • 公开(公告)号: US20160031859A1
    公开(公告)日: 2016-02-04
  • 发明人: Alexandre Vasilievich Ivachtchenko
  • 申请人: Andrey Alexandrovich IVASHCHENKONikolay Filippovich SAVCHUKAlexandre Vasilievich IVACHTCHENKO
  • 优先权: RU2013105163 20130207
  • 国际申请: PCT/RU2014/000079 WO 20140204
  • 主分类号: C07D403/14
  • IPC分类号: C07D403/14
Alkyl [(S)-1-((S)-2--buta-1,3-diynyl)-phenyl]-1H-imidazol-2-yl}-pyrrolidine-1-carbonyl)-2-methyl-propyl]-carbamate naphthalene-1,5-disulfonate, pharmaceutical composition, medicament, method for treatment of viral diseases
摘要:
The present invention relates to NS5A inhibitors, to novel pharmaceutical composition, antiviral medicament, method for prophylaxis and treatment of viral diseases, in particular caused by hepatitis C (HCV) virus and hepatitis GBV-C virus.Alkyl [(S)-1-((S)-2-{5-[4-(4-{2-[(S)-1-((S)-2-methoxycarbonylamino-3-methyl-butyryl)-pyrrolidin-2-yl]-3 H-imidazol-4-yl}-buta-1,3-diynyl)-phenyl]-1H-imidazol-2-yl}-pyrrolidine-1-carbonyl)-2-methyl-propyl]-carbamate naphthaline-1,5-disulfonate of the general formula 1, possibly in crystalline or polycrystalline form, have been proposed, wherein: R is C1-C3 alkyl.
信息查询
0/0